Interaction of the pathogenic mold Aspergillus fumigatus with lung epithelial cells
1Department of Clinical Microbiology and Immunology, Aspergillus and Antifungal Research Laboratory, Sackler School of Medicine, Tel-Aviv University Ramat-Aviv, Tel-Aviv, Israel.
Abstract:
Aspergillus fumigatus is an opportunistic environmental mold that can cause severe allergic responses in atopic individuals and poses a life-threatening risk for severely immunocompromised patients. Infection is caused by inhalation of fungal spores (conidia) into the lungs. The initial point of contact between the fungus and the host is a monolayer of lung epithelial cells. Understanding how these cells react to fungal contact is crucial to elucidating the pathobiology of Aspergillus-related disease states. The experimental systems, both in vitro and in vivo, used to study these interactions, are described. Distinction is made between bronchial and alveolar epithelial cells. The experimental findings suggest that lung epithelial cells are more than just "innocent bystanders" or a purely physical barrier against infection. They can be better described as an active extension of our innate immune system, operating as a surveillance mechanism that can specifically identify fungal spores and activate an offensive response to block infection. This response includes the internalization of adherent conidia and the release of cytokines, antimicrobial peptides, and reactive oxygen species. In the case of allergy, lung epithelial cells can dampen an over-reactive immune response by releasing anti-inflammatory compounds such as kinurenine. This review summarizes our current knowledge regarding the interaction of A. fumigatus with lung epithelial cells. A better understanding of the interactions between A. fumigatus and lung epithelial cells has therapeutic implications, as stimulation or inhibition of the epithelial response may alter disease outcome.
Insights
Lung epithelial cells actively defend against Aspergillus fumigatus by identifying spores and mounting an immune response. These cells are crucial for understanding and potentially treating fungal-related lung diseases.
Area of Science:
- Pulmonary immunology
- Microbiology
- Cell biology
Background:
- Aspergillus fumigatus is an opportunistic pathogen causing allergic reactions and life-threatening infections in immunocompromised individuals.
- Fungal spores (conidia) are inhaled, with lung epithelial cells representing the initial host interaction site.
- Understanding epithelial cell responses is key to Aspergillus-related disease pathobiology.
Purpose of the Study:
- To review current knowledge on the interaction between Aspergillus fumigatus and lung epithelial cells.
- To elucidate the role of lung epithelial cells in the host response to fungal infection.
- To highlight the therapeutic implications of modulating epithelial cell responses.
Main Methods:
- Review of in vitro and in vivo experimental systems studying A. fumigatus-epithelial cell interactions.
- Distinction between bronchial and alveolar epithelial cell responses.
- Analysis of cellular and molecular mechanisms involved in host defense and allergy.
Main Results:
- Lung epithelial cells act as an active component of the innate immune system, not just a physical barrier.
- Epithelial cells identify fungal spores and initiate defense mechanisms, including conidia internalization and release of antimicrobial factors.
- These cells can modulate immune responses, releasing anti-inflammatory compounds like kinurenine during allergic reactions.
Conclusions:
- Lung epithelial cells play a dynamic role in host defense against Aspergillus fumigatus.
- Modulating epithelial cell responses offers potential therapeutic strategies for Aspergillus-related diseases.
- Further research into these interactions is vital for improving patient outcomes.
Related Concept Videos
Fungal Phylum Ascomycota
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...


